plegridy- peginterferon beta-1a injection, solution plegridy pen- peginterferon beta-1a injection, solution plegridy- peginter
biogen inc. - peginterferon beta-1a (unii: i8309403r0) (peginterferon beta-1a - unii:i8309403r0) - peginterferon beta-1a 94 ug in 0.5 ml - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. plegridy is contraindicated in patients with a history of hypersensitivity to natural or recombinant interferon beta or peginterferon, or any other component of plegridy [see warnings and precautions ( 5.3)] . risk summary data from a large population-based cohort study, as well as other published studies over several decades, have not identified a drug-associated risk of major birth defects with the use of interferon beta products during early pregnancy. findings regarding a potential risk for low birth weight or miscarriage with the use of interferon beta products in pregnancy have been inconsistent (see data). in a study in pregnant monkeys, administration of interferon beta during pregnancy resulted in an increased rate of abortion (see data ). in the u.s. general population, the estimated backgro
plegridy peginterferon beta-1a (rch) 63 microgram/0.5 ml and 94 microgram/0.5 ml solution for injection pre-filled pen titration pack
biogen australia pty ltd - peginterferon beta-1a, quantity: 94 microgram - injection, solution - excipient ingredients: arginine hydrochloride; water for injections; sodium acetate trihydrate; polysorbate 20; glacial acetic acid - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see clinical trials).
plegridy peginterferon beta-1a (rch) 125 microgram/0.5 ml solution for injection pre-filled syringe
biogen australia pty ltd - peginterferon beta-1a, quantity: 125 microgram - injection, solution - excipient ingredients: sodium acetate trihydrate; water for injections; glacial acetic acid; arginine hydrochloride; polysorbate 20 - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see clinical trials).
plegridy peginterferon beta-1a (rch) 63 microgram/0.5 ml and 94 microgram/0.5 ml solution for injection pre-filled syringe titration pack
biogen australia pty ltd - peginterferon beta-1a, quantity: 94 microgram - injection, solution - excipient ingredients: glacial acetic acid; polysorbate 20; arginine hydrochloride; sodium acetate trihydrate; water for injections - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see clinical trials).
plegridy peginterferon beta-1a (rch) 125 microgram/0.5 ml solution for injection pre-filled pen
biogen australia pty ltd - peginterferon beta-1a, quantity: 125 microgram - injection, solution - excipient ingredients: sodium acetate trihydrate; glacial acetic acid; water for injections; polysorbate 20; arginine hydrochloride - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see clinical trials).
plegridy 125
medison pharma ltd - peginterferon beta 1a - solution for injection - peginterferon beta 1a 125 mcg / 0.5 ml - peginterferon beta-1a - plegridy is indicated in adult patients for the treatment of relapsing remitting multiple sclerosis
plegridy 63
medison pharma ltd - peginterferon beta 1a - solution for injection - peginterferon beta 1a 63 mcg / 0.5 ml - peginterferon beta-1a - plegridy is indicated in adult patients for the treatment of relapsing remitting multiple sclerosis
plegridy 94
medison pharma ltd - peginterferon beta 1a - solution for injection - peginterferon beta 1a 94 mcg / 0.5 ml - peginterferon beta-1a - plegridy is indicated in adult patients for the treatment of relapsing remitting multiple sclerosis
plegridy kit
biogen canada inc - peginterferon beta-1a; peginterferon beta-1a - kit - 63mcg; 94mcg - peginterferon beta-1a 63mcg; peginterferon beta-1a 94mcg - interferons
plegridy
biogen netherlands b.v. - peginterferon beta-1a - multiple sclerosis - immunostimulants, - treatment of relapsing remitting multiple sclerosis in adult patients.